Institut de Science et d'Ingénierie Supramoléculaires (ISIS), CNRS UMR 7006, Université de Strasbourg, 8 Allée Gaspard Monge, 67000, Strasbourg, France.
Institut Universitaire de France (IUF), 75005, Paris, France.
Angew Chem Int Ed Engl. 2023 Oct 9;62(41):e202309289. doi: 10.1002/anie.202309289. Epub 2023 Aug 31.
β-(Hetero)arylethylamines appear in a myriad of pharmaceuticals due to their broad spectrum of biological properties, making them prime candidates for drug discovery. Conventional methods for their preparation often require engineered substrates that limit the flexibility of the synthetic routes and the diversity of compounds that can be accessed. Consequently, methods that provide rapid and versatile access to those scaffolds remain limited. To overcome these challenges, synthetic chemists have designed innovative and modular strategies to access the β-(hetero)arylethylamine motif, paving the way for their more extensive use in future pharmaceuticals. This review outlines recent progresses in the synthesis of (hetero)arylethylamines and emphasizes how these innovations have enabled new levels of molecular complexity, selectivity, and practicality.
β-(杂芳基)乙胺因其广泛的生物特性而存在于众多药物中,使其成为药物发现的首选候选物。它们的常规制备方法通常需要经过工程设计的底物,这限制了合成路线的灵活性和可获得化合物的多样性。因此,能够快速且灵活地获得这些支架的方法仍然有限。为了克服这些挑战,合成化学家设计了创新和模块化的策略来获得β-(杂芳基)乙胺基序,为它们在未来药物中的更广泛应用铺平了道路。本文综述了(杂芳基)乙胺的合成研究进展,并强调了这些创新如何使分子复杂性、选择性和实用性达到新的水平。